Kilian Kelly
Chief Executive Officer chez CYNATA THERAPEUTICS LIMITED
Fortune : 65 142 $ au 31/03/2024
Profil
Kilian Kelly is currently the Chief Executive Officer & Managing Director at Cynata Therapeutics Ltd.
He is also a Member of the Regulatory Affairs Professionals Society, the Royal Pharmaceutical Society of Great Britain, the International Society for Cellular Therapy, the Australian Institute of Co. Directors, and The Organisation for Professionals in Regulatory Affairs Ltd.
In the past, Dr. Kelly held the position of Senior Director-Drug Development at Aviragen Therapeutics, Inc. and Vice President-Regulatory & Clinical at Mesoblast Ltd.
Dr. Kelly obtained a doctorate degree from the University of Strathclyde and a graduate degree from The Robert Gordon University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
30/06/2023 | 525 508 ( 0,29% ) | 65 142 $ | 31/03/2024 |
Postes actifs de Kilian Kelly
Sociétés | Poste | Début |
---|---|---|
CYNATA THERAPEUTICS LIMITED | Chief Executive Officer | 01/07/2023 |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Corporate Officer/Principal | - |
The Organisation for Professionals in Regulatory Affairs Ltd
The Organisation for Professionals in Regulatory Affairs Ltd Miscellaneous Commercial ServicesCommercial Services The Organisation for Professionals in Regulatory Affairs Ltd is a professional membership organization that provides training courses, conferences, and networking opportunities for individuals engaged in regulatory affairs for human and veterinary medicines and medical devices worldwide. The non-profit company is based in London, UK. The organization offers resources for improving professional competence and industry standing, including newsletters, medical device resources, and a glossary of regulatory affairs terms. | Corporate Officer/Principal | - |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD. | Corporate Officer/Principal | - |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Corporate Officer/Principal | - |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Corporate Officer/Principal | - |
Anciens postes connus de Kilian Kelly
Sociétés | Poste | Fin |
---|---|---|
MESOBLAST LIMITED | Chief Tech/Sci/R&D Officer | - |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Corporate Officer/Principal | - |
Formation de Kilian Kelly
University of Strathclyde | Doctorate Degree |
The Robert Gordon University | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
MESOBLAST LIMITED | Health Technology |
CYNATA THERAPEUTICS LIMITED | Health Technology |
Entreprise privées | 6 |
---|---|
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Regulatory Affairs Professionals Society is a non-profit organization that offers healthcare products. The non-profit company is based in Rockville, MD. | Commercial Services |
Royal Pharmaceutical Society of Great Britain
Royal Pharmaceutical Society of Great Britain Miscellaneous Commercial ServicesCommercial Services The Royal Pharmaceutical Society of Great Britain provides expertise and support to its member pharmacists. The private company is based in Great Britain. Alex MacKinnon has been the CEO of the British company since 2010. | Commercial Services |
International Society for Cellular Therapy
International Society for Cellular Therapy Miscellaneous Commercial ServicesCommercial Services International Society for Cellular Therapy conducts research, processing, and manipulation of cells. The private company is based in Vancouver, CA. The Canadian company publishes researched materials. and has subsidiaries in the United States. | Commercial Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Commercial Services |
The Organisation for Professionals in Regulatory Affairs Ltd
The Organisation for Professionals in Regulatory Affairs Ltd Miscellaneous Commercial ServicesCommercial Services The Organisation for Professionals in Regulatory Affairs Ltd is a professional membership organization that provides training courses, conferences, and networking opportunities for individuals engaged in regulatory affairs for human and veterinary medicines and medical devices worldwide. The non-profit company is based in London, UK. The organization offers resources for improving professional competence and industry standing, including newsletters, medical device resources, and a glossary of regulatory affairs terms. | Commercial Services |
Aviragen Therapeutics, Inc.
Aviragen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aviragen Therapeutics, Inc. engages in the discovery and development of direct-acting antivirals to treat infections. Its product candidates include vapendavir, an oral treatment for human rhinovirus infections in moderate-to-severe asthmatics; BTA074, a topical antiviral treatment for genital warts caused by human papillomavirus types 6 & 11; BTA585, an oral fusion protein inhibitor for the treatment of RSV-A and RSV-B infections; and laninamivir octanoate, a one-time, inhaled treatment for influenza A and B infections. The company was founded on November 8, 2012 and is headquartered in Alpharetta, GA. | Health Technology |